PDF's Last Days In US: Industry Works To Solve Its FDA Application Problem

The goal is a platform where sponsors could enter data that multiple regulators could view in real-time, rather than rely on ‘digital paper’ – pdfs and other static file formats that require health agencies to reenter the data in order to analyze it.

Public Meeting: Modernizing FDA Data Strategy virtual meeting — FDA PRINCIPAL DEPUTY COMMISSIONER AMY ABERNETHY WAS AMONG THE PARTICIPANTS AT THE AGENCY'S 30 JUNE PUBLIC MEETING ON MODERNIZING ITS DATA STRATEGY.

A group of pharma companies is working to potentially streamline application submission and assessment by ending their reliance on so-called digital paper.

The project, known as Accumulus, involves creating a platform that would allow for rolling data flow, instead of the boluses...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Navamedic To Market OTC Naloxone In Norway Following Switch

21 Jul 2025

• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Green Regulation Is ‘A Baseline Not A Burden’ – Behind Opella’s B Corp Journey

21 Jul 2025

• By David Ridley

“For us, regulation is the floor, not the ceiling,” Opella's chief sustainability officer Marissa Saretsky tells HBW Insight as the firm gains B Corp Certification. Other topics covered in this exclusive interview include Opella's position on the revised Urban Wastewater Treatment Directive.